Views & Analysis How blockchain will revolutionise clinical trials The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs.
Views & Analysis Why pharma companies need to upgrade their intelligence Pairing AI capabilities with human strengths can bring a competitive edge in this rapidly-changing world.
Views & Analysis Graph power: life sciences lead in intelligent data use Graph technology is allowing pharma to model data in a way that offers invaluable insights for marketing, R&D and compliance teams alike.
Views & Analysis Making data science a part of the life sciences sales strate... Since the dawn of the age of ‘big data’, the life sciences industry has seen exponential growth in the amount of customer data readily available – an amount that is set to continue to grow at a
Views & Analysis Back up data to rebuff ransomware bullies Nick Claxson offers a useful guide to keeping data secure from the cybercriminals.
Views & Analysis Impact of data management on clinical trials: new study The correlation between the upfront time to build and release a clinical database and its impact on downstream data management.
Oncology Breaking barriers to CAR T-cell therapy: The vision for expa... Live from ASCO 2025: Prof. Dr Jason Westin discusses CAR-T Vision, patient access, and the push to expand therapy reach in rare blood cancers.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
